Related Experiment Video
Updated: Sep 8, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Ipratropium bromide and noninvasive ventilation treatment for COPD
Sheng Lin1, Xiaoqin Li1, Baosong Xie1
1Department of Respiratory and Critical Care Medicine, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University Fuzhou 350001, Fujian Provincial, China.
Combining ipratropium bromide with non-invasive ventilation significantly improves outcomes for patients suffering from chronic obstructive pulmonary disease (COPD) and respiratory failure. This treatment enhances blood gas indexes, lung function, and quality of life while reducing adverse events.
Area of Science:
- Pulmonary Medicine
- Critical Care Medicine
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) and respiratory failure represent significant clinical challenges.
- Non-invasive ventilation (NIV) is a cornerstone in managing respiratory failure.
- Optimizing pharmacological adjuncts to NIV is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of combining ipratropium bromide with NIV in COPD patients experiencing respiratory failure.
- To compare outcomes between patients receiving NIV alone versus those receiving ipratropium bromide plus NIV.
Main Methods:
- A prospective study involving 110 patients with COPD and respiratory failure.
- Group A received standard NIV; Group B received ipratropium bromide combined with NIV.
- Outcomes assessed included blood gas indexes, pulmonary function, treatment efficacy, quality of life, and adverse reactions.
Main Results:
- The combination therapy group (Group B) demonstrated significant improvements in blood gas indexes and pulmonary function compared to NIV alone (Group A) (P < 0.05).
- Group B exhibited lower levels of inflammatory factors (P < 0.05).
- Treatment efficacy, quality of life, and safety profiles were superior in Group B, with fewer adverse reactions (P < 0.05).
Conclusions:
- Ipratropium bromide in conjunction with non-invasive ventilation offers a highly effective treatment strategy for COPD patients with respiratory failure.
- This combined approach leads to enhanced physiological parameters, improved clinical outcomes, and a better safety profile.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Inhaled Medications
Mechanical Ventilation I: Indication and Settings

